Chronic migraine: comorbidities, risk factors, and rehabilitation.
about
Managing migraine by patient profile: role of frovatriptanAnti-CGRP monoclonal antibodies in migraine: current perspectives.Refractory chronic migraine: a consensus statement on clinical definition from the European Headache Federation.Chronic migraine plus medication overuse headache: two entities or not?OnabotulinumtoxinA 155 U in medication overuse headache: a two years prospective study.A two years open-label prospective study of OnabotulinumtoxinA 195 U in medication overuse headache: a real-world experience.New insights into the cardiovascular risk of migraine and the role of white matter hyperintensities: is gold all that glitters?Altered kynurenine pathway metabolites in serum of chronic migraine patientsMigraine: Clinical pattern and psychiatric comorbidityCephalalgiaphobia as a feature of high-frequency migraine: a pilot studyAdherence with migraine prophylaxis in clinical practice.Quarterly repeat cycles of onabotulinumtoxinA in chronic migraine patients: the benefits of the prolonged treatment on the continuous responders and quality-of-life conversion rate in a real-life setting.Chronic migraine treatment: from OnabotulinumtoxinA onwards.Dispute settlement understanding on the use of Botox in chronic migraine.Serotonin receptor agonists in the acute treatment of migraine: a review on their therapeutic potential.A Critical Evaluation on MOH Current Treatments.Migraine: incorrect self-management for a disabling disease.
P2860
Q27002977-53D0919E-779B-4888-AB68-DB9848966240Q34531880-31083A5F-8B11-4E22-A128-94305458FFE3Q34544375-29B1AA27-A790-4273-B621-A584F1986AE5Q35522746-FBE77435-776B-4B41-8F0D-4196A329DE6BQ36415380-795B3546-DDAB-407F-A877-B90B28FBA8AAQ36484239-2080EB82-025C-43E1-956D-D9A86DE1DE67Q36750079-4E1349EE-D0D5-4E79-B3F0-7B5C1C2D7ACAQ36853404-C85B1285-C897-4897-B521-B9EF775F4CD4Q36917614-E14EC9BF-BE5A-4560-B369-ADA3B1842DE6Q36940443-F8F21761-DB6D-4D48-A50E-243DDF6D1CB0Q38434618-F7A53722-570E-40E1-B308-23C97639360FQ38670983-C18A322E-8333-4219-B5EC-5B0F3832624BQ38866988-DBC751D6-C759-4853-9D68-C55F290AE1D6Q42682895-EA30FF66-C1D8-4AB5-90A2-B42EFB337933Q52643768-B970AC86-3ABF-4905-8882-32628B9D8133Q54795534-A68E3EC3-CDB3-4542-AFCF-3C0896C60A25Q55392147-992D3E4A-2483-4AAD-8053-095A5FD1547C
P2860
Chronic migraine: comorbidities, risk factors, and rehabilitation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chronic migraine: comorbidities, risk factors, and rehabilitation.
@en
Chronic migraine: comorbidities, risk factors, and rehabilitation.
@nl
type
label
Chronic migraine: comorbidities, risk factors, and rehabilitation.
@en
Chronic migraine: comorbidities, risk factors, and rehabilitation.
@nl
prefLabel
Chronic migraine: comorbidities, risk factors, and rehabilitation.
@en
Chronic migraine: comorbidities, risk factors, and rehabilitation.
@nl
P2860
P1476
Chronic migraine: comorbidities, risk factors, and rehabilitation.
@en
P2093
Andrea Negro
Lidia D'Alonzo
P2860
P2888
P356
10.1007/S11739-010-0457-7
P478
P577
2010-10-01T00:00:00Z